Soyeon has broad experience leading engagements spanning the product life cycle and supporting clients across the life sciences industry including large pharma and biotech. She has worked extensively across all major therapeutic areas and project types, with particular interest in neurology / neuropsychiatry, rare diseases, and portfolio and therapeutic area strategy. In her work, Soyeon emphasizes a collaborative and data-driven approach to drive to tailored, actionable strategic insights for clients.
Prior to joining ClearView, Soyeon received her Ph.D. in Biological Sciences from Columbia University, where her thesis work focused on gene therapy applications in Parkinson’s disease. Soyeon earned her B.A. from the University of Pennsylvania in Biology with a concentration in Neuroscience.
Debbi Amanti Belanger